13F
中

PRME PRIME MEDICINE INC

2026Q1 · CUSIP 74168J101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
190
Δ holders QoQ
+7
Breadth percentile
Top 37%
Whale holders
100
Δ whales
+5
Inst. holding value
$340M
New positions
39
Closed positions
32
Price momentum (1Q)
-15.1%
Put / Call
3/3

Breadth history (34 quarters)

2023Q1: Δ+9 · h=76 2023Q2: Δ+4 · h=80 2023Q3: Δ+4 · h=84 2023Q4: Δ+21 · h=105 2024Q1: Δ+10 · h=115 2024Q2: Δ+7 · h=122 2024Q3: Δ-6 · h=116 2024Q4: Δ+15 · h=131 2025Q1: Δ-6 · h=125 2025Q2: Δ-2 · h=123 2025Q3: Δ+44 · h=167 2025Q4: Δ+16 · h=183 2026Q1: Δ+7 · h=190 2023Q1: holders=76 2023Q2: holders=80 2023Q3: holders=84 2023Q4: holders=105 2024Q1: holders=115 2024Q2: holders=122 2024Q3: holders=116 2024Q4: holders=131 2025Q1: holders=125 2025Q2: holders=123 2025Q3: holders=167 2025Q4: holders=183 2026Q1: holders=190 -44 -22 +0 +22 +44 68134200 23Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 5% -12.8% -25.9%
2023Q1 Top 18% -9.1% -49.9%

Options Sentiment

Put holders
3
QoQ: 0
Call holders
3
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.23
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -0.44 2023-06-30: EPS -0.47 2023-09-30: EPS -0.55 2023-12-31: EPS -0.72 2024-03-31: EPS -0.44 2024-06-30: EPS -0.46 2024-09-30: EPS -0.44 2024-12-31: EPS -0.31 2025-03-31: EPS -0.40 2025-06-30: EPS -0.41 2025-09-30: EPS -0.32 2025-12-31: EPS -0.22 2026-03-31: EPS -0.28 -0.79 -0.40 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)